Find the Perfect Plan for Your Investment Journey
V
Latest price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$398.32M |
EV | CA$396.14M |
Shares Outstanding | 787.41M |
Beta | 0.34 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | 1.60x |
Revenue | 22.20% |
EPS | 18.20% |
Operating Cash Flow | 30.50% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 50.20% |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -141.74% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
V
Vireo Growth Inc.
VREO
Sector
Industry
CEO
Shimpa, Amber
Employees
470
Website
vireohealth.comIPO Date
Headquarters
207 South Ninth Street, Minneapolis, Minnesota, 55402, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved